European regulators said they were reviewing the safety of two popular oral diabetes drugs, Actos and Avandia following rare case of eye problems that may be associated with the medicines.
The European Medicines Agency said yesterday rare episodes of macular oedema, or swelling of the back of the eye, had been reported with GlaxoSmithKline Plc’s Avandia and Takeda Pharmaceutical Co Ltd’s Actos.
The agency’s Committee for Medicinal Products for Human Use will now carry out a review to establish whether there is a link between macular oedema and the use of the drugs, which belong to a class of diabetes treatments known as glitazones.
The medicines work by making the body’s cells more sensitive to insulin, thereby helping people with type II, or adult-onset, diabetes to better use their own natural insulin.
Start your own walking program.
New StepTracker Available at special prices. See the results of the Step Program Study.
Purchase your own pedometers and receive the Steps to Health Program at no charge. http://www.rx4betterhealth.com/steptracker/
The Only Pedometer on the Market That Comes With a Program for Success!
DID YOU KNOW:
The number of people with dementia around the world will double every 20 years, predicts a new report. A new case of dementia is diagnosed every seven seconds, according to the paper published in today’s Lancet, or 4.6 million each year. By 2040 the numbers with dementia will have risen to 81.1 million, from 24.3 million today. The figures will give further impetus to research into dietary approaches that can help prevent or slow the onset of the disease. A study published this month in the Archives of Neurology found that people who ate two or more fish meals a week had a slower rate of cognitive decline than non-fish eaters.